Oct. 12 (Thu.) ,2017 13:30-16:00

Annex Hall
F202

Simultaneous Interpretation

【S-7】 Flanders Investment & Trade

The 18th Flanders Lifesciences Seminar

Decades of advanced knowhow, academically-trained and entrepreneurial people, and continuous innovation: these are the main ingredients that have made Flanders, the northern region of Belgium, a world leader in life sciences. More than 200 life sciences companies are working closely with universities, research institutes and hospitals. They form a mature and unique life sciences cluster in the heart of Europe. 9 leading organizations/companies from Flanders will participate in this seminar and demonstrate how various organizations/companies are operating a world-class research infrastructure and how they interact in a successful and efficient way to create the present strength of Belgium-Flanders in biotechnology and life sciences.

Coordinator

Ben Kloeck

Technology Director, Flanders Invesetment & Trade

Opening Wordd and Presentation "From Science to Value"

Lieve Ongena

Sr Science Policy Manager, flanders.bio

The road to become one of the leading life sciences clusters

Henk Joos

Managing Director, VIB

Building Your Future Life Science Product with IMEC’s Smart Silicon Chip Solutions

Veerle Reumers

R&D Team Leader Life Sciences and Imaging, Imec

Novosanis, game-changing medical devices

Vanessa Vankerckhoven

CEO | Co-Founder, Novosanis

Improving Accuracy In Diagnostics, Prevention And Treatment In Infectious Diseases and Oncology

Bart Roucourt

Contract Research Manager, reMynd

Strike the cancer, not the patient

Jens De Vos

Chief Operating Officer ❘ Co-founder, Camel-IDS

Your Professional & Experienced Partner

Thomas Ockier

Managing Director, Andacon

Towards personalized quality & engineering in advanced therapy R&D.

Jan Schrooten

Co-Founder & Managing Director, Antleron

Developing Highly Differentiated Antibody Therapeutics

Arjen Lemmen

Director Business Development , argenx

Building a regional community to kick-start a revolution in medicine

Jan Schrooten

Board of Directors of FlandersBio, Flanders Investment & Trade

Closing word

Ben Kloeck

Technology Director

Close Window